Chemoinformaics analysis of 1-butyl-2-methylbenzene
| Molecular Weight | 148.249 | nRot | 3 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 6 |
| Exact Molecular Weight | 148.125 | nRing | 1 |
| Solubility: LogS | -4.571 | nHRing | 0 |
| Solubility: LogP | 4.502 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 29.0387 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.616 |
| Synth | 1.377 |
| Natural Product Likeliness | -0.542 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.006 |
| HIA | 0.002 |
| CACO-2 | -4.318 |
| MDCK | 0.0000181 |
| BBB | 0.836 |
| PPB | 0.9578 |
| VDSS | 2.399 |
| FU | 0.036 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.878 |
| CYP2c19-inh | 0.804 |
| CYP2c19-sub | 0.571 |
| CYP2c9-inh | 0.52 |
| CYP2c9-sub | 0.775 |
| CYP2d6-inh | 0.24 |
| CYP2d6-sub | 0.853 |
| CYP3a4-inh | 0.17 |
| CYP3a4-sub | 0.284 |
| CL | 8.485 |
| T12 | 0.337 |
| hERG | 0.063 |
| Ames | 0.013 |
| ROA | 0.06 |
| SkinSen | 0.489 |
| Carcinogencity | 0.338 |
| EI | 0.995 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.794679 |